http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111110693-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-713 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-713 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088 |
filingDate | 2020-01-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2021-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2021-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-111110693-B |
titleOfInvention | Application of agent for down-regulating expression of circular gene in preparation of medicine for preventing and/or treating pulmonary fibrosis and medicine |
abstract | The invention relates to application of a reagent for down-regulating expression of cyclic has _ circ _0023858 in preparation of a medicament for preventing and/or treating pulmonary fibrosis and a medicament for down-regulating expression of cyclic has _ circ _0023858, belonging to the technical field of medicament preparation. The medicine prepared by the reagent for down-regulating the expression of the cyclic has _ circ _0023858 can realize prevention and/or treatment of pulmonary fibrosis, and particularly prevents or treats pulmonary fibrosis by regulating a Hippo signal pathway through miR-324-5p adsorption; can inhibit differentiation, activation, proliferation and migration of lung fibroblast. |
priorityDate | 2020-01-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 273.